Tracy Warren

Tracy Warren serves as general partner of Astarte Ventures, an early stage venture firm focused on women’s & children’s health & wellbeing. Currently, Tracy also serves as a general partner of Battelle Ventures and its affiliate fund, Innovation Valley Partners, for which she focuses on investments in health & life sciences. Tracy has led investments in NuPathe, which completed its IPO in 2010 and was subsequently acquired by Teva Pharmaceuticals. She currently serves as Chairman of BioNano Genomics & on the Board of Micro Interventional Devices. Alongside Dr. Cymbeline Culiat, Ms. Warren co-founded NellOne Therapeutics, a soft-tissue regenerative medicine company based on the NELL1 gene and Dr. Culiat’s work at Oak Ridge National Lab. As CEO, she leads the company’s efforts with respect to strategy, fundraising, & business development. Tracy also provides early-stage leadership to other businesses, currently serving as an adviser & mentor to female entrepreneurs through Springboard.

Past Events

• Speaker, MedtechVISION 2015 – Panel 3: Investment Opportunities in Women’s Health
  

Videos